We focus on conditions that affect women disproportionately, including gynaecological disorders and inflammatory and inflammatory diseases.
We find the reproductive system fascinating. It is a dynamic, ever-changing environment shaped by hormonal cycles, tissue-resident immune cells and age. The most striking example is the endometrium, the uterine mucosal lining, which sheds and then regenerates perfectly and without scarring — roughly 400 times over a lifetime.
This system is crucial for the perpetuation of the species and the transmission of genetic information to the next generation, and equally for maternal and fetal health and the lifelong health of the newborn. Defects in communication between the uterus and the placenta, a transient extraembryonic tissue, can profoundly alter developmental outcomes. Beyond reproduction, the hormones this system produces place it at the centre of women’s health more broadly. Understanding it comprehensively therefore matters regardless of whether a woman chooses to have children.
Reproductive disorders are a major global health burden, and one that is too often endured in silence. Around 10% of people born with a uterus are affected by endometriosis, and ovarian cancer remains one of the most aggressive cancers affecting people with ovaries.
The reproductive system also offers a uniquely powerful window onto general rules of tissue physiology. During menstruation the endometrium is destroyed and becomes inflammatory, then resolves that inflammation itself in order to regenerate without scarring — a rare example of inflammation resolving in an entirely physiological setting, and a model for how we might improve repair at other epithelial surfaces. In pregnancy, the same tissue becomes immunomodulatory, allowing embryo and mother to coexist despite a genetic mismatch that could otherwise trigger rejection — a natural setting in which to study how immune tolerance is induced, with relevance well beyond reproduction.